2009
DOI: 10.1007/978-3-540-89208-3_373
|View full text |Cite
|
Sign up to set email alerts
|

The Impact of Model-based Therapeutics on Glucose Control in an Intensive Care Unit

Abstract: -This paper investigates the impact of fast parameter identification methods, which do not require any forward simulations, on model-based glucose control, using retrospective data in the Christchurch Hospital Intensive Care Unit. The integral-based identification method has been previously clinically validated and extensively applied in a number of biomedical applications; and is a crucial element in the presented model-based therapeutics approach. Common non-linear regression and gradient descent approaches … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2011
2011
2013
2013

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 11 publications
0
2
0
Order By: Relevance
“…Measurements are available with a maximum relative error of 15% on the readings. This high noise level is consistent with the accuracy of recent CGMSs . Uncertainty on the prior estimation of the metabolic parameters is taken into account during the design phase assuming an initial guess on model parameters of θ 0 = [0.0235 0.0189 0.92 E -5] T , corresponding to a relative deviation of 40% from the true metabolic parameters θ describing the physiology of the diabetic subject.…”
Section: Case Study 2: Optimal Design Of a Clinical Test For The Iden...mentioning
confidence: 58%
“…Measurements are available with a maximum relative error of 15% on the readings. This high noise level is consistent with the accuracy of recent CGMSs . Uncertainty on the prior estimation of the metabolic parameters is taken into account during the design phase assuming an initial guess on model parameters of θ 0 = [0.0235 0.0189 0.92 E -5] T , corresponding to a relative deviation of 40% from the true metabolic parameters θ describing the physiology of the diabetic subject.…”
Section: Case Study 2: Optimal Design Of a Clinical Test For The Iden...mentioning
confidence: 58%
“…It is assumed that the "synthetic" glucose measurements (obtained by simulation of HWM at Θ) are modelled as follows: a. discrete sampling: blood glucose measurements are corrupted by Gaussian noise with zero mean and a constant relative deviation of 0.03; b. CGMS: following Hann et al (2009), the measurements are supposed to be affected by a 7% low frequency modelling error added to a 18 % Gaussian mean error:…”
Section: Case Studymentioning
confidence: 99%